Abstract and Summary can be submitted to the following sections:
The deadline for submission has been extended to August 15, 2024.
Notification for acceptance: August 30, 2024
Abstracts must be submitted electronically.
Abstracts may be submitted in any discipline related to pediatric ophthalmology, including strabismus, pediatric cataract, pediatric glaucoma, pediatric oculoplastic diseases, pediatric retinal diseases, refractive errors, pediatric corneal or anterior segment diseases, amblyopia, pediatric neuro-ophthalmology, orthoptic evaluation, or epidemiology.
Abstracts should be submitted in the following format:
o Title of abstract (maximum 50 words)
o Authors
o Presenting author
o Background (Purpose)
o Methods
o Results
o Conclusions
The total number of words in the abstract, excluding title and authors, should not exceed 300 words.
The abstract title must not include any trade names. They may, however, be used in the content of your text.
No author or institution name should be featured in the body of the abstract.
Authors will have the choice during their submission to decide whether they want their abstract presented as a poster only, an oral presentation only, or in either format.
For posters, the submitting author does not need to attend the meeting, but registration of the submitting author is mandatory. For all oral presentations, presenting author must attend the Free Paper Session and present their abstract in a PowerPoint presentation. All oral presentations will be discussed in the session. No pre-recorded oral presentations will be allowed.
The deadline for submission has been extended to August 15, 2024.
Abstracts will be sent for scoring, and the submitting author will be notified by the decision by August 30, 2024.
Maximum number of accepted abstracts for each presenting author is 2 abstracts.
All presenting authors will be required to register for the meeting before August 30, 2024
